Oct. 22 at 6:45 PM
$TEVA
$ SPRY
This is long game for me!!
$ SPRY — The Next EpiPen Standard
First and only needle-free FDA + internationally approved treatment for type 1 allergic reactions (anaphylaxis). Launching by some of the same team that helped launch Narcan — patent protected to 2038.
Highlights:
•
$250M non-dilutive funding
• Approvals: 🇺🇸 USA, 🇬🇧 UK, 🇩🇪 Germany, 🇪🇺 Europe, 🇯🇵 Japan
• Coming soon: 🇨🇦 Canada, 🇳🇿 New Zealand, Australia?
• 30-month shelf life → lower cost, wider adoption
• Insurance & school programs expanding fast
• Currently in Phase 2 trials for treatment of hives (urticaria)
My opinion only — do your own research.
Good luck to all!
The video below had over 7 million views but it was removed and reposted!
https://youtu.be/INqeijbY9Q4